TL;DR. SSRIs and SNRIs produce a fairly predictable set of skin changes: dry skin from mild anticholinergic effects, more sweating in some users (especially venlafaxine and sertraline), increased sun sensitivity, and occasional early rashes. None of this is reason to stop a medication that is helping. It is reason to adjust the routine. The skincare changes are small. The medication is the work.
Up front: do not change your psychiatric medication based on a skincare article. The medications below save lives, and the side effects are mostly manageable. If your skin is part of why you’re considering stopping, talk to your prescriber first. There is almost always a way to manage the skin without stepping back on the mental health work.
What this article does cover is the patterns I see in our reader mail and that are documented in the dermatology literature. Knowing what to expect is most of the battle.
What is happening, by drug class
SSRIs (sertraline, escitalopram, fluoxetine, paroxetine, citalopram) and SNRIs (venlafaxine, duloxetine) are the most common pharmacological treatments for anxiety. They work by changing serotonin and (for SNRIs) norepinephrine reuptake. Skin effects come from secondary actions: mild anticholinergic shifts that reduce some glandular secretions, sympathetic nervous system changes that can increase sweating, and changes to thermoregulation and appetite.
Tricyclic antidepressants, sometimes prescribed for anxiety, have stronger anticholinergic effects and produce more pronounced dry skin and dry mouth. Buspirone has a milder side-effect profile. Benzodiazepines have minimal direct skin effects but can affect sleep architecture, which indirectly affects skin recovery.
Why it happens, in plain language
Serotonin is not only a brain chemical. It is also present in the gut, blood vessels, and skin, and it modulates sebum production, vascular tone, and local inflammation. When you change central serotonin with an SSRI, you also nudge those peripheral systems. The net effect varies by person.
The dry-skin pattern is the most common. Glandular output drops slightly, including sebum and sweat. Skin loses moisture more readily, especially in low-humidity environments. The sweating pattern shows up in roughly 10 to 15 percent of SSRI users and a higher percentage of SNRI users. Venlafaxine is particularly associated with treatment-emergent sweating; the mechanism involves serotonergic modulation of the autonomic nervous system. The sweating is usually at night and can be heavy enough to affect sleep.
The sun-sensitivity pattern is the one most often missed. Several SSRIs are listed by the FDA as having mild to moderate photosensitivity potential. The presentation is often a sunburn at lower UV exposure than the user is used to. Early rashes in the first four to six weeks occur in roughly 1 to 4 percent of patients. Most are mild and self-limited. Any spreading rash with mucosal involvement is a medical emergency.
What helps
For dryness: a fatty moisturizer at night, applied to damp skin within three minutes of cleansing. A humectant serum during the day with glycerin and a low-molecular-weight hyaluronic acid. Microbiome Glow Serum works well here because the postbiotic ferments and glycerin base hydrate without adding actives that more sensitive skin may not tolerate. Skip strong actives until skin equilibrates, usually two to three months in.
For sweating: light breathable fabrics at night, a cooler bedroom, and a cleanser you actually use after sweat-heavy nights, even a water rinse. Don’t let dried sweat sit on the chest and back; it triggers folliculitis in a meaningful subset of users.
For sun sensitivity: daily broad-spectrum SPF 30 or higher, with a quarter teaspoon for the face. Be especially diligent in the first six months of a new prescription. Reapply every two hours outdoors. For early rashes: photograph the rash, note timing relative to the dose, and contact your prescriber.
The contrarian take: don’t blame the medication for everything
The most common pattern in reader mail is a user who started an SSRI six months ago, has had skin changes, and now blames every breakout on the medication. This is sometimes correct. It is often partially wrong.
Anxiety itself changes skin. Chronic anxiety raises cortisol, disrupts sleep, increases skin picking, and changes eating and hydration patterns. When the SSRI starts working and the anxiety drops, some of the skin changes you blame on the medication are actually the receding waterline of the anxiety, which had been doing visible damage for months. The honest read is that the medication and the underlying anxiety both affect skin, and separating them takes time.
When to see a dermatologist
See a dermatologist for any rash in the first two months of a new medication that is spreading, blistering, or involving mucosal surfaces (mouth, eyes, genitals). This is rare but it is the presentation of Stevens-Johnson syndrome and related severe drug reactions, which need urgent care.
For non-urgent issues, see a derm for persistent rashes after the first few months, sweat-related skin infections that don’t clear with home care, sun sensitivity producing severe sunburns at low UV exposure, and any skin finding your psychiatrist flags. Bring the medication list; the derm needs it.
The real numbers
The FDA prescribing information for sertraline (Zoloft) lists treatment-emergent hyperhidrosis in approximately 7 percent of patients in clinical trials, compared to approximately 3 percent on placebo. For venlafaxine (Effexor), the rate is 12 to 19 percent depending on dose, compared to 4 percent on placebo. A 2014 review in the Journal of the American Academy of Dermatology summarized cutaneous adverse reactions to psychotropic medications across many studies, finding early-treatment rashes in 1 to 4 percent of SSRI users, severe cutaneous adverse reactions in less than 1 in 10,000 users, and the most consistent finding being the dry skin / dry mouth pattern of anticholinergic effect.
For more, see our barrier repair protocol, microbiome explainer, and the dehydration tag hub.
FAQ
My SSRI is making me sweat at night. Is there anything topical I can do? Aluminum chloride antiperspirants applied to the chest and back at night can reduce sweat output meaningfully and are generally safe. Ask your psychiatrist about a dose adjustment or a switch within the class; some SSRIs cause less sweating than others.
Will my skin go back to normal if I stop the medication? For most users, dryness and sweating side effects resolve within two to four weeks of stopping. The underlying anxiety often returns, which has its own skin consequences. Don’t stop for the skin alone without a real conversation with your prescriber.
Can I use a retinoid while on an SSRI? Generally yes, if skin is otherwise stable and you’ve been on the medication for at least a few months. Start at low concentration and frequency.
I think my SSRI is causing my acne. What do I do? Photograph the timeline, track the dose, and bring it to your psychiatrist and possibly a dermatologist. The fix is rarely stopping the medication; more often it is a routine adjustment plus, if needed, a separate acne treatment.
Sources
Mitkov MV et al. Dermatologic side effects of psychotropic medications. JAAD.org/” rel=”noopener” target=”_blank”>Journal of the AAD.org/” rel=”noopener” target=”_blank”>American Academy of Dermatology, 2014. Krasowska D et al. Cutaneous effects of the most commonly used antidepressant medication. Journal of the American Academy of Dermatology, 2007. FDA. Sertraline (Zoloft) prescribing information, 2023 revision. National Institute of Mental Health. Mental Health Medications, NIH Publication, 2023.